Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Periodontal Disease Treatment Market Forecast: What Market Value Is Expected By 2030?

The market for periodontal disease treatments has experienced robust expansion recently, projected to increase from $1.67 billion in 2025 to $1.79 billion in 2026, reflecting a compound annual growth rate of 7.0%. Several factors contributed to this past growth, including the widespread occurrence of gingivitis and periodontitis, a deficiency in public knowledge regarding available treatments, a common reliance on traditional dental care approaches, insufficient early detection methods, and a dispersed system for delivering dental services.

The market for treating periodontal disease is projected for substantial expansion, anticipated to reach \$2.33 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.8%. This upward trajectory in the upcoming years is fueled by several key factors, including the development of less invasive surgical techniques, increased utilization of regenerative therapies and bone grafting procedures, the proliferation of dental practices and research institutions, heightened public understanding and demand for gum health treatments, and the integration of digital technologies and interconnected oral care systems. Significant trends expected to shape this period involve the growing application of artificial intelligence for early detection and patient risk assessment, the wider adoption of digital and cloud-based patient records, the escalating use of Internet of Things (IoT) devices for monitoring treatment outcomes, the implementation of smart manufacturing processes for dental instruments used in periodontics, and a greater emphasis on tailoring periodontal treatments based on genetic information.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21253&type=smp

Periodontal Disease Treatment Market Opportunity Drivers: What Is Creating New Revenue Potential?

The increasing prevalence of issues related to oral health is anticipated to fuel the expansion of the market for periodontal disease treatments in the future. Oral health challenges encompass conditions that impact the teeth, gums, and mouth, such as cavities, gum infections, oral ailments, and oral malignancies. Factors contributing to the escalating rates of these oral health problems include inadequate oral hygiene practices, detrimental dietary habits, consumption of tobacco and alcohol, an aging global population, and restricted availability of dental services. Treatments for periodontal disease are employed to control and avert oral health complications by targeting gum infections, inflammation, and the deterioration of supporting bone structures. As an illustration, in March 2025, the World Health Organization (WHO), a governmental public health entity headquartered in Switzerland, indicated that approximately 3.7 billion individuals are estimated to be affected by oral diseases. Consequently, the burgeoning occurrence of oral health disorders is poised to drive the expansion of the periodontal disease treatment market.

Periodontal Disease Treatment Market Segmentation And Category Breakdown

The periodontal disease treatment market covered in this report is segmented –

1) By Type: Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Other Types

2) By Treatment Type: Non-Surgical Treatment, Scaling And Root Planning, Medication, Surgical Treatment, Flap Surgery, Bone Grafts, Other Treatment Types

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

5) By End-User: Hospitals, Clinic, Dental Clinic, Dental Academics And Research Institutes, Other End-Users

Subsegments:

1) By Gingivitis: Plaque-Induced Gingivitis, Non-Plaque-Induced Gingivitis

2) By Chronic Periodontal Disease: Mild Periodontitis, Moderate Periodontitis, Severe Periodontitis

3) By Aggressive Periodontal Disease: Localized Aggressive Periodontitis, Generalized Aggressive Periodontitis

4) By Other Types: Necrotizing Periodontal Disease, Periodontitis Associated With Systemic Conditions

Periodontal Disease Treatment Market Innovation Trends Driving Future Development

Leading entities within the periodontal disease therapeutics sector are actively engaged in pioneering advancements, such as the creation of specialized dental gels aimed at fostering bone regrowth, increasing treatment availability, minimizing procedural intrusion, and presenting superior, more amenable options compared to conventional periodontal interventions. Dental gel, essentially a medicinal preparation for oral application, incorporates agents with antibacterial, anti-inflammatory, or fluoride properties, serving the dual purpose of cavity prevention and management of gum ailments, while also alleviating oral discomfort. As an illustration, during October of 2024, Oral Biolife Inc., a bioscience firm headquartered in the United States, unveiled Ambrilux Dental Gel, a revolutionary therapeutic engineered to stimulate bone regeneration in cases of periodontal disease, which has demonstrated encouraging outcomes in extensive animal studies. The successful validation conducted on Beagle dogs, revealing a complete absence of bone loss and a demonstrable increase in bone mass across all subjects receiving the treatment, suggests that this novel development holds the potential to transform non-surgical dental care paradigms for both human and veterinary patients, tackling a substantial gap in current medical provisions.

Periodontal Disease Treatment Market Competitive Analysis Of Major Industry Participants

Major companies operating in the periodontal disease treatment market are Bausch Health Companies Inc, DENTSPLY SIRONA Inc., Straumann AG, Sunstar Suisse S.A, NovaBone Products LLC, Nakanishi Inc., Brasseler USA, Geistlich Pharma AG, BIOLASE Inc., Bien-Air Dental, Convergent Dental Inc., Carl Martin GmbH, Karl Schumacher, Yoshida Dental MFG. Co. Ltd., Botiss Biomaterials GmbH, Millennium Dental Technologies Inc., PreXion Inc., AMD Lasers Inc., Steris Healthcare Pvt Ltd, Perio Protect, Deppeler SA.

Access The Complete Periodontal Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/periodontal-disease-treatment-global-market-report

Periodontal Disease Treatment Market Regional Analysis And Leading Geography

North Americawas the largest region in the periodontal disease treatment market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the periodontal disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model